focus -WSS

focus

author：leisure time 2025-09-05 13:43:53 - browse：4

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： U.K. officials, researchers try to ease path for bespoke genetic treatments

knowledge

WSS

Pfizer, Moderna say biotech, pharma drug development is a sprint

6 surprising facts about sugar

Pfizer, Moderna say biotech, pharma drug development is a sprint

Anavex keeps shifting the goalposts in its clinical trials

What to know about Virgin Galactic's 1st mission taking paying customers to space

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Wikipedia

focus

The need-to-know this morning

Novavax’s money is going in the wrong direction

entertainment

Jerome Adams on the need for new antivirals for Covid

Erich Jarvis studies song birds to learn about human stuttering

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mirador, a new biotech startup, launches with $400 million

Trump demands the U.S. pay no more for drugs than other countries … again

Wegovy trial has doctors encouraged over new possibilities

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Wegovy’s successful heart trial raises vital question about weight loss

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Diabetes management: Digital health tools fall short, study says

focus

Wegovy trial has doctors encouraged over new possibilities

Surgeons perform first xenotransplant using CRISPR'd pig kidney

CRISPR technology availability, affordability needs to be expanded

Wegovy’s successful heart trial raises vital question about weight loss

South Korea throws huge K

Methadone doses haven’t kept up in the age of fentanyl

leisure time

knowledge

hotspot

entertainment